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Fig 1: Hemodynamic data sampled at 30 sec by the 
Advisor and GTN infusion rate (µg/kg/min)
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We have previously reported, via the ARS forum, on a real-time Decision Support System 
(DSS). We report on its first clinical patient trial.  
 
Informed consent was obtained from a 73 year old patient undergoing routine aortic valve 
surgery. The peri-operative care was provided by the treating anaesthetist and surgeon. The trial 
commenced on ICU following completion of surgery, prior to awakening and endotracheal 
extubation.  After calibration of the LiDCO monitor, the target parameters (systolic BP 110-130 
mmHg, CVP 6-10) were selected by the treating anaesthetist, and inputted to the DSS screen by 
the study anaesthetist. The CVP 
was manually updated via the DSS 
interface. The real-time patient 
data displayed successfully 
alongside, and illuminated the 
‘low/normal/high’ boxes of the 
hemodynamic classifier.  
The DSS commenced its advice by 
selecting GTN as the targeted 
infusion due to rising hypertension, 
and each 30 seconds suggested an 
infusion rate in µg/kg/min to the 
study anaesthetist. If the 
anaesthetist agreed, then the 
syringe motif would be clicked-on 
and the infusion rate would 
immediately and manually be 
input-in to the Graseby 3400 
pump. As shown in Fig. 1, 
control was commenced with a 
rising systolic blood pressures peaking at 138 mmHg, matched by rising GTN infusion rates for 
approximately  30 minutes. The self-tuning advisor achieved better control henceforth stabilizing 
the systolic pressure at around 120 ± 5 mmHg. The anaesthetist did not overrule the DSS at any 
point during the trial by inputting each infusion rate as suggested. Control has been maintained 
for approximately 70 minutes at which time the trial was electively ended. 
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